🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

493 results for “Regeneron UK Limited” Clear

  1. REGN4336

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial

  2. REGN4461

    Regeneron UK Limited

    Familial Partial Lipodystrophy

    phase 2 small molecule terminated

    1 trial

  3. REGN475

    Regeneron UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    1 trial

  4. REGN475

    Regeneron UK Limited

    Osteoarthritis

    phase 2 mab terminated

    1 trial

  5. REGN475

    Regeneron UK Limited

    Sciatica

    phase 2 small molecule completed

    1 trial

  6. REGN475/SAR164877

    Regeneron UK Limited

    Back Pain

    phase 2 small molecule terminated

    1 trial

  7. REGN475/SAR164877

    Regeneron UK Limited

    Abdominal Pain Upper

    phase 2 small molecule terminated

    1 trial

  8. REGN5069

    Regeneron UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  9. REGN5093

    Regeneron UK Limited

    NSCLC

    phase 2 small molecule active

    1 trial

  10. REGN5381

    Regeneron UK Limited

    Uncontrolled Hypertension

    phase 2 small molecule terminated

    1 trial

  11. REGN5381

    Regeneron UK Limited

    Heart Failure

    phase 2 small molecule terminated

    2 trials

  12. REGN5459

    Regeneron UK Limited

    Relapsed Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  13. REGN5668

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  14. REGN5678

    Regeneron UK Limited

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  15. REGN7041

    Regeneron UK Limited

    Active Noninfectious Uveitis Affecting the Posterior Segment

    phase 2 small molecule active

    1 trial

  16. REGN7075

    Regeneron UK Limited

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  17. REGN7508

    Regeneron UK Limited

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial

  18. REGN7544

    Regeneron UK Limited

    Postural Orthostatic Tachycardia Syndrome (POTS)

    phase 2 small molecule active

    1 trial

  19. REGN7544

    Regeneron UK Limited

    Sepsis-Induced Hypotension

    phase 2 small molecule completed

    1 trial

  20. REGN7999

    Regeneron UK Limited

    Non-Transfusion Dependent Beta-Thalassemia (NTDT)

    phase 2 small molecule active

    1 trial

  21. REGN846

    Regeneron UK Limited

    Pruritus

    phase 2 small molecule terminated

    1 trial

  22. REGN910-3

    Regeneron UK Limited

    Neovascular Age-Related Macular Degeneration

    phase 2 small molecule completed

    2 trials

  23. REGN910-3

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 2 small molecule completed

    1 trial

  24. REGN9933

    Regeneron UK Limited

    Venous Thromboembolism

    phase 2 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources